Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

67.22 +0.37 (+0.55%)
Streaming Delayed Price Updated: 10:29 AM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,571,064
Open 67.10
Bid (Size) 67.22 (1)
Ask (Size) 67.24 (3)
Prev. Close 66.85
Today's Range 66.95 - 67.70
52wk Range 52.77 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 3.60%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Via Benzinga
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... 
Via Benzinga

Performance

YTD
-16.86%
-16.86%
1 Month
+18.05%
+18.05%
3 Month
+15.48%
+15.48%
6 Month
-3.61%
-3.61%
1 Year
-6.29%
-6.29%

More News

Read More
What the Options Market Tells Us About CVS Health
Via Benzinga
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl'
Via Benzinga
Exposures Regulatory
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Looking At CVS Health's Recent Unusual Options Activity
Via Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
Biotech Stocks Poised For Another Big Move In Q4
Via Talk Markets
Does This New Development Make CVS Stock a Buy or a Sell?
Via The Motley Fool
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
Via The Motley Fool
An Activist Investor Is Interested in CVS; We Take a Look
Via The Motley Fool
What Analysts Are Saying About CVS Health Stock
Via Benzinga
Stock Of The Day: Is It Time To Sell CVS?
Via Benzinga
This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Via Benzinga
Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Via Investor's Business Daily
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
Via Benzinga
Instacart Is Revolutionizing Groceries: Why It's Time to Invest
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here’s Why Surgery Partners Could Be the Next Hot Takeover
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.